Get the Stockscreener App
1.02
38.02%
0.281
After Hours:
.81
-0.21
-20.59%
Onconetix Inc stock is traded at $1.02, with a volume of 6.12M.
It is up +38.02% in the last 24 hours and up +22.21% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
See More
Previous Close:
$0.739
Open:
$0.7385
24h Volume:
6.12M
Relative Volume:
13.52
Market Cap:
$4.03M
Revenue:
$735.20K
Net Income/Loss:
$-9.70M
P/E Ratio:
-0.00234
EPS:
-435.729
Net Cash Flow:
$-9.80M
1W Performance:
+66.59%
1M Performance:
+22.21%
6M Performance:
-96.98%
1Y Performance:
-99.29%
1-Day Range:
$0.7106
$1.05
1-Week Range:
$0.5868
$1.05
52-Week Range:
$0.5868
$209.50
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
1.02 | 2.63M | 735.20K | -9.70M | -9.80M | -435.73 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Onconetix Inc Stock (ONCO) Latest News
Could Onconetix (NASDAQ:ONCO) Face More Volatility on Nasdaq? - Kalkine Media
Why Is Onco Micro-Cap Stock Surging 50% In Premarket? - Stocktwits
Onconetix Inc (ONCO) Stock Price, Quote, News & History - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
Onconetix Inc (NASDAQ: ONCO) Share Price, ONCO Stock News, ONCO Share Price & Updates - Kalkine
Onconetix, Inc. SEC Filing (Sep 4, 2026) | ONCO EFFECT - Stock Titan
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - Yahoo Finance
Onconetix (NASDAQ: ONCO) flags going concern as 100M-share resale filed - Stock Titan
Onconetix Inc Key Financial Ratios – Valuation, Profitability & More - Value Research
Onconetix Inc Peer Comparison – Compare with Others - Value Research
Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingReturn On Assets - dars.gov.et
Onconetix (ONCO) flags going concern risk as cash burn, impairments mount - Stock Titan
Onconetix (NASDAQ: ONCO) resale filing covers 100M shares tied to PIPE - Stock Titan
Realbotix Q3 Results: Revenue Falls 40%, Loss Widens Amid Scaling - scanx.trade
Realbotix Plans Online-Only Robot Line With Buyer Deposits in 2026 - Stock Titan
Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
ONCO Stock Price, Quote & Chart - ChartMill
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - The Manila Times
Onconetix (ONCO) outlines Realbotix all-stock acquisition and humanoid robot TV role - Stock Titan
Onconetix subsidiary appoints co-founder to board - Investing.com
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Nigeria
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - The Manila Times
ONCO Q1 2025 Earnings: Positive EPS of $0.25 Marks a Notable Bottom-Line QuarterBanking Earnings Report - vinanet.vn
Onconetix Inc (ONCO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Onconetix Secures Major PIPE and Equity Facility Financing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Onconetix (NASDAQ: ONCO) adds $750,000,000 ELOC and $30,249,600 PIPE - Stock Titan
Onconetix (ONCO) 13G: Keystone Capital reports 6.1% beneficial stake - Stock Titan
Onconetix Inc. (ONCO) Gains 3.46% as Shares Approach Resistance at $0.89Factor Timing - dars.gov.et
Onconetix Inc (ONCO) Balance Sheet - TradingKey
Onconetix Inc (ONCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Onconetix Inc (ONCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Onconetix Inc|Price:0.821|Chg%:+0.032 - TradingKey
Onconetix Inc (ONCO) Income Statement - TradingKey
Onconetix Inc (ONCO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Onconetix Inc. Q1 2025 Earnings: Posts Positive EPS Amid Quiet QuarterEarnings Power Value - dars.gov.et
TradingKey - TradingKey
ONCO|Onconetix Inc|Price:0.821|Chg%:+0.032 - TradingKey
ONCO|Onconetix Inc|Price:0.667|Chg%:-0.044 - TradingKey
Onconetix Inc Revenue Breakdown – FWB:J4T - TradingView
Onconetix Inc (ONCO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Realbotix has two separate businesses: humanoid robots and adult wellness - Stock Titan
Realbotix separates commercial robotics and consumer operations - scanx.trade
This New York School Is Becoming a Humanoid Robot Company's Biggest Test. There's Just 1 Problem - inc.com
Onconetix (ONCO) stock surges over 23% overnight: Why is it moving? - MSN
Onconetix (ONCO) Bounces 7.88% Off Support: Can the Biotech Stock Sustain Its Recovery?RSI Oversold Picks - vinanet.vn
Onconetix Inc. (ONCO) Retreats Toward Support After 2.35% DeclineMACD Signal Stocks - dars.gov.et
Onconetix Inc. (ONCO) Facing Support Test as Shares Slide 2.35%Risk Reversal - vinanet.vn
Onconetix Inc. (ONCO) Edges Higher but Faces Key Resistance Near $0.83Weak Sell Signals - dars.gov.et
ONCO Q1 2025 Earnings: Surprise Profit Amid Absent Revenue and Steep Stock DeclineEarnings Call Transcript - vinanet.vn
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation - The Manila Times
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Onconetix Inc Stock (ONCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Apr 17 '26 |
Buy |
0.73 |
34,636 |
25,284 |
177,821 |
| HRT FINANCIAL LP | 10% Owner |
Apr 20 '26 |
Sale |
0.75 |
94,462 |
70,846 |
83,359 |
| HRT FINANCIAL LP | 10% Owner |
Apr 16 '26 |
Sale |
0.73 |
53,867 |
39,323 |
143,185 |
| HRT FINANCIAL LP | 10% Owner |
Apr 15 '26 |
Buy |
0.76 |
92,554 |
70,341 |
197,052 |
| HRT FINANCIAL LP | 10% Owner |
Apr 14 '26 |
Buy |
0.77 |
74,350 |
57,250 |
104,498 |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):